canada_flag  Ottawa, Canada

“CADTH believes that credible, objective evidence should inform every important health care decision.”
– Suzanne McGurn, President and CEO, CADTH

History and Structure

Created in 1989, CADTH is an independent, not-for-profit organization funded by Canada’s federal, provincial, and territorial governments, with the exception of Quebec.

CADTH provides Canada’s health care decision-makers with objective evidence to help make informed decisions about the optimal use of drugs, medical devices, diagnostics, and procedures in our health care system.

Over the years, CADTH has grown to be a key resource to the health care system. With a customer-service and strategic approach, CADTH priorities are driven by the needs of Canada’s health care system and its practices are based on documented methods and guidelines that reflect the latest thinking in evidence-informed decision-making.

Among other things, CADTH:

  • helps health care decision-makers keep pace with technological change
  • reviews and make recommendations on new and existing health technologies
  • undertakes comprehensive Health Technology Assessments that leverage the full depth and power of today’s evidence-rich environment
  • examines practices, processes, and protocols to provide a better understanding of the current landscape in health care
  • scans the horizon to give health care leaders a glimpse of what the future might bring.

Mission

CADTH consistently delivers credible scientific evidence and management strategies that enable the appropriate use of health technologies.

How CADTH Works

As a pan-Canadian organization, CADTH works with health care decision-makers, industry, associations and other interested parties to ensure that all Canadians benefit from evidence-based information, recommendations and advice.

Patients and clinicians are among the most important beneficiaries of CADTH’s work, and CADTH strives to engage them in meaningful and constructive ways through its committees and panels and through input and feedback opportunities. Stakeholder input provides CADTH with invaluable insight through a real-world lens.

CADTH is accountable to the federal, provincial and territorial Conference of Deputy Ministers of Health through the CADTH Board of Directors.

Core services are primarily provided through three program areas:

  • Drug Reimbursement Recommendations
  • Health Technology Management
  • Scientific Advice.

Dissemination Activities

To advance Canada’s capacity to use evidence as the basis for sound health care decisions, CADTH undertakes a range of activities to facilitate interaction, collaboration, and knowledge exchange between itself, Canadian health care decision makers, and partner organizations throughout the world.

Evidence-based information produced by CADTH is readily available at no cost through its website (www.cadth.ca). Results are also published as detailed technical reports, overviews, bulletins, alerts and articles in peer-reviewed journals. CADTH researchers present their work at national and international academic conferences and workshops and have been involved in the development of national consensus guidelines.

Key areas of collaboration and outreach include:

Implementation Support and Knowledge Mobilization

  • Comprised of professionals located across the country, this team actively reaches out to understand the needs of decision-makers in different jurisdictions, to build strong relationships, and to help put evidence to work at a local level. Knowledge mobilization is the key to getting maximum impact from evidence.
  • Partnerships and Linkages harness the power of collaboration, both nationally and internationally, to share information, transfer best practices, and work together on key strategic issues.

Advisory Committees

  • Our structure of advisory bodies provides us with the counsel and expertise of authorities in a variety of key disciplines that are vital to the quality of our work. The members of these bodies also serve as ambassadors for evidence-informed decision-making.
  • CADTH collaborates with many other HTA agencies across Canada. A recent CADTH environmental scan identified over 40 HTA groups in provincial government, academic institutions, hospitals, and regional health authorities.

The pan-Canadian Health Technology Assessment (HTA) Collaborative

  • The Collaborative was formed in 2011 to share best practices, minimize duplication of effort through the sharing of information, and identify and contribute to joint initiatives in the assessment of health technologies (medical devices, procedures, and diagnostics).
  • Fostering collaboration among regional HTA producers is promoted as a core value and guiding principle of the Collaborative. The Collaborative engages collectively to enhance the development and use of HTA in Canada to improve patient outcomes and health system sustainability. To accomplish this, the Collaborative brings together representatives from provincial and pan-Canadian HTA producers.

Current Projects

Information on current and upcoming projects may be obtained from the CADTH web site (www.cadth.ca).

Future Plans

CADTH is committed to continuous improvement and transparency. As part of the goals and objectives outlined in CADTH’s 2018-2021 Strategic Plan, work is underway to continue:

    • Closing the gap between evidence, policy, and practice
    • Adopting a life-cycle approach to health technology assessment
    • Anticipating health system and technology trends, and develop agile management strategies

 

Agency Information

Country: Canada
Description of population served: National
Population served (mil): 37.5
Current HTA budget (mil USD): 28.2m
Permanent staff: over 200
Consultants: variable
Ongoing TA projects: 25-35


Contact information

Director: Suzanne McGurn
Contact person: Suzanne McGurn

Canadian Agency for Drugs and Technologies in Health
865 Carling Avenue, Suite 600
K1S 5S8 Ottawa, Ontario Canada

Tel: +1 613 226 2553
Fax: +1 613 226 5392
Internet: http://www.cadth.ca
Email: suzanne.mcgurn@cadth.ca